UPDATE: H.C. Wainwright Starts Talaris Therapeutics (TALS) at Buy, PT $18
Tweet Send to a Friend
(Updated - October 20, 2022 6:29 AM EDT)
H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Talaris Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Talaris Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
